A phase 2 trial of dasatinib in patients with advanced HER2-positive and/or hormone receptor-positive breast cancer

Erica L. Mayer, Jean Francois Baurain, Joseph Sparano, Lewis Strauss, Mario Campone, Pierre Fumoleau, Hope Rugo, Ahmad Awada, Oumar Sy, Antonio Llombart-Cussac

Research output: Contribution to journalArticlepeer-review

67 Scopus citations

Fingerprint Dive into the research topics of 'A phase 2 trial of dasatinib in patients with advanced HER2-positive and/or hormone receptor-positive breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences